Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Tryptophan is metabolized along the kynurenine and serotonin pathways, resulting in formation of kynurenine metabolites, neuroactive serotonin and melatonin. Each pathway is critical for maintaining healthy homeostasis. However, the two pathways are extremely unequal in their ability to degrade tryptophan, and little is known about the mechanisms maintaining the balance between them. Here, we demonstrated that in PC 12 cells, a change of expression of key genes of one pathway resulted in a change of expression of key genes of the other. Melatonin, the end product of the serotonin pathway, played an important role in tryptophan metabolism by affecting both key enzymes of the two pathways. Melatonin treatment induced the expression of indole‐2,3‐dioxygenase 1 (IDO 1) and enhanced the activity of the IDO 1 promoter while decreasing the expression of arylalkylamine N‐acetyl transferase. Melatonin treatment up‐regulated the expression of forkhead box protein O1 (FoxO1) and enhanced the binding of FoxO1 to the IDO 1 promoter. FoxO1 was shown to be a new regulator for IDO 1 expression. Melatonin treatment decreased the phosphorylation of FoxO1 by extracellular signal‐regulated kinases 1 and 2 and protein kinase B (Akt) and increased the phosphorylation of binding protein 14‐3‐3 by c‐Jun N‐terminal kinase (JNK), and thus the complex of FoxO1–14‐3‐3 in the cytoplasm was disassembled and FoxO1 was relocated to the nucleus to induce IDO 1 expression. The JNK signaling pathway played an important role in melatonin‐induced IDO 1 up‐regulation. In conclusion, this study suggests a link between melatonin, JNK, FoxO1 and IDO 1 that acts as a potential balance regulator of tryptophan metabolism, and offers a new approach to treat diseases related to dysregulation of tryptophan metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305 · cited 1×
“The overexpression of IDO1 has been found in the dendritic cells (DCs), tumor-draining lymph nodes (TDLNs) and in a variety of tumor cells [25, 26].”
BackgroundKynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Indoleamine 2,3 dioxygenase and metabolic control of immune responses
Munn, D. H., & Mellor, A. L. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.10.001 · Cited by 1,037 · cited 1×
“It has also been known that IDO1 plays crucial roles in various infectious diseases, fetal rejection, organ transplantation, neuropathology diseases, autoimmune disorders and cancers by reducing the availability of tryptophan [27-30] and producing its downstream metabolites (such as KYN and QUIN) as well as metabolite…”
BackgroundInterferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437
Miura, H., Ozaki, N., Sawada, M., Isobe, K., Ohta, T., & Nagatsu, T. (2008) · Stress · doi:10.1080/10253890701754068 · Cited by 282
Cited by
Zhu, F., Guo, R., Wang, W., Ju, Y., Wang, Q., Ma, Q., Sun, Q., Fan, Y., Xie, Y., Yang, Z., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0475-4 · Cited by 323
Huang, Y., Zhao, M., Chen, X., Zhang, R., Le, A., Hong, M., Zhang, Y., Jia, L., Zang, W., Jiang, C., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0916 · Cited by 138
“TDO is present mainly in the liver [21].”
BackgroundMachine learning approaches for biomarker discovery to predict large-artery atherosclerosis
Sun, T.-H., Wang, C.-C., Wu, Y.-L., Hsu, K.-C., & Lee, T.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-42338-0 · Cited by 32
“Variable N LAA, N = 1761 Control, N = 1831 p-value2 Age 359 64 (58, 69) 61 (56, 66) 0.”
Savino, R., Carotenuto, M., Polito, A. N., Di Noia, S., Albenzio, M., Scarinci, A., Ambrosi, A., Sessa, F., Tartaglia, N., & Messina, G. (2020) · doi:10.20944/preprints202007.0425.v1 · Cited by 54
Metadata
- Authors
- Li, Y., Hu, N., Yang, D., Oxenkrug, G., & Yang, Q.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2017-02-20
- Volume
- 284
- Issue
- 6
- Pages
- 948-966
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2580057498
- Cited by
- 98
- References
- 7
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. https://app.cochat.ai/papers/10.1111/febs.14026
- The paper
- Li, Y., Hu, N., Yang, D., Oxenkrug, G., & Yang, Q. (2017). Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. The FEBS Journal. https://doi.org/10.1111/febs.14026
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.